Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
ONCOLOGY-NEW YORK
Journal
Overview
Identity
Other
View All
Overview
publication venue for
Mark A. Socinski, MD, on Progression of Lung Cancer Treatment
2022
ACR Appropriateness Criteria (R) Adjuvant Management of Early-Stage Endometrial Cancer
. 30:816-822.
2016
ACR Appropriateness Criteria (R) Adjuvant Therapy in Vulvar Cancer
. 29:867-+.
2015
Do Oncogenic Drivers Exist in Squamous Cell Carcinoma of the Lung?
. 27:906-+.
2013
Intraoperative Radiotherapy for Breast Cancer: Its Perceived Simplicity
. 27:107-113.
2013
Current Status of Robot-Assisted Radical Prostatectomy: Progress Is Inevitable
2012
ALK-Targeted Therapy in NSCLC: Likely to Be of Benefit but Not Quite Ready for Prime Time THE HUSAIN/RUDIN ARTICLE REVIEWED
2011
The Many Controversies of Stage IIIA/IIIB Lung Cancer The Balmanoukian/Ettinger article reviewed
2010
Phase I/II trial of irinotecan, carboplatin, and paclitaxel in advanced or metastatic NSCLC.
2000
Identity
International Standard Serial Number (ISSN)
0890-9091
Electronic International Standard Serial Number (EISSN)
2767-7389
Other
journal abbreviation
ONCOLOGY-NY
Oncology (Williston Park)